SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR and INZY on Behalf of Shareholders

Group 1 - Halper Sadeh LLC is investigating Charter Communications, Inc. for potential violations related to its merger with Cox Communications [1] - Inozyme Pharma, Inc. is being sold to BioMarin Pharmaceutical Inc. for $4.00 per share [2] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]